KORU Medical Systems
Gian Dakari Connor has extensive work experience in the field of business development and strategic partnerships. Currently, they are the Director of Business Development and Strategic Partnerships at KORU Medical Systems, where they focus on rare diseases and leads negotiations related to global regulatory submissions, device development, and clinical affairs. Prior to this role, Gian worked at Corning Incorporated as the Director and Senior Manager of New Business Development. Gian Dakari also held positions at SCHOTT as the Senior Manager of Corporate Strategy and Business Development Manager for Glass Syringes. Additionally, they worked at WEIDMANN Medical Technology AG as a Key Account Manager and at Gerresheimer as a Sales and Business Development Manager, Associate Sales and Business Development Manager, and Quality Systems Consultant. In their previous roles, Gian organized projects, improved quality control processes, programmed information systems, and trained staff on quality control technology.
Gian Dakari Connor has a Bachelor of Science (BS) degree in Marketing from Rowan University. In addition, they have studied Intercultural Competencies at Universität Osnabrück. Prior to that, they attended Washington Township High School. Gian also has some certifications, including a German Language Certificate of Undergraduate Study. Gian Dakari has not specified the institution where they obtained this certification or the month and year. Furthermore, they have studied Business Administration and Management at Widener University, although it is unclear if they obtained a degree in this field.
This person is not in any teams
This person is not in any offices
KORU Medical Systems
The home infusion industry turns to KORU Medical Systems to help patients and medical professionals improve infusion therapy experiences and we have a passion and vision for doing just that! We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers with careful consideration to the patient experience. The company was incorporated in March 1980 and is now publicly traded on the NASDAQ Capital Market (NASDAQ: KRMD). We are located in Mahwah, NJ (USA), approximately 30 miles northwest of New York City. Our primary products include the FREEDOM60® and FreedomEdge® Syringe Infusion Systems, Precision Flow Rate Tubing™, and HIgH-Flo Subcutaneous Safety Needle Sets.